First Horizon Advisors, Inc. Prothena Corp Public LTD CO Call Options Transaction History
First Horizon Advisors, Inc.
- $3.81 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRTA
# of Institutions
216Shares Held
34.3MCall Options Held
769KPut Options Held
1.1M-
Black Rock Inc. New York, NY3.86MShares$38.3 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$22.2 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$20.4 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY1.54MShares$15.3 Million0.25% of portfolio
-
Adar1 Capital Management, LLC Austin, TX1.47MShares$14.6 Million1.35% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $466M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...